The expansion of active BAT particularly in individuals with obesity might harbor the potential to counteract metabolic deterioration usually seen in this population, given the positive impact of BAT on energy homeostasis and beneficial BAT-derived hormones acting on peripheral insulin sensitivity and hepatic lipid handling (2, 14, 15). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.